Skip to main content
Fresenius SE & Co. KGaA logo

Fresenius SE & Co. KGaA — Investor Relations & Filings

Ticker · FRE ISIN · DE0005785604 LEI · XDFJ0CYCOO1FXRFTQS51 F Human health and social work activities
Open in API
Filings indexed 1,398 across all filing types
Latest filing 2007-03-05 Director's Dealing
Country DE Germany
Listing F FRE

About Fresenius SE & Co. KGaA

https://www.fresenius.com/

Fresenius SE & Co. KGaA is a global healthcare company that provides system-critical products and services for leading therapies for the care of critically and chronically ill patients. The company's portfolio encompasses a wide range of products and services for dialysis, hospitals, and outpatient medical care. Key offerings include intravenously administered generic drugs, biopharmaceuticals, biosimilars, clinical nutrition, and infusion therapies. Additionally, the company operates a large network of private hospitals and outpatient centers. Through its strategic investment in Fresenius Medical Care, it is a leading global provider of products and services for individuals with renal diseases.

Recent filings

Filing Released Lang Actions
DGAP-DD: Fresenius AG english
Director's Dealing Classification · 100% confidence The document explicitly uses the header "Directors’ Dealings" and details a transaction made by a person performing managerial responsibilities (Gerd Krick, Member of an administrative or supervisory body) involving the company's ordinary shares. This directly matches the definition for Director's Dealing (DIRS). The reference to section 15a of the WpHG and the structure of the notification confirm this is an insider transaction report.
2007-03-05 English
Fresenius AG: Release according to article 26a, section 1 WpHG [Securities Trading Act] with the aim of a Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Total Voting Rights' and explicitly states that it is a 'Release according to article 26a, section 1 WpHG' announcing the total number of voting rights as of the end of February 2007. This directly relates to the official results or status of voting rights within the company, which aligns best with the Declaration of Voting Results & Voting Rights Announcements (DVA) category. Although it is a short announcement, the content is specific to voting rights status, not just announcing the publication of a larger report.
2007-03-02 English
Declaration of Voting Results & Voting Rights Announcements 2007
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document explicitly states in the title and body that it is a 'Release of a Voting rights announcement according to article 21, section 1 WpHG'. It details changes in voting rights thresholds crossed by several related entities (Julius Baer Investment Management LLC, Julius Baer Americas Inc., Julius Bär Holding AG) concerning Fresenius AG. This directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). Although it is a regulatory announcement, DVA is a more specific category than the general RNS.
2007-03-02 English
Fresenius AG: Outstanding 2006 financial results
Earnings Release Classification · 100% confidence The document is an 'Ad hoc announcement' dated February 22, 2007, detailing 'Outstanding 2006 financial results' including Group sales, EBIT, net income, and earnings per share, along with a positive outlook for 2007. It explicitly mentions financial performance for a completed period (2006) and provides key figures, which is characteristic of an Earnings Release (ER). Although it contains detailed figures, its format as a brief, immediate 'Ad hoc announcement' transmitting key highlights rather than a comprehensive quarterly or annual report (like 10-K or IR) strongly suggests it is the initial announcement of results. FY 2006
2007-02-22 English
Presentation FY 2006, February 22nd, 2006
Investor Presentation Classification · 95% confidence The document is a detailed presentation from an analyst meeting held on February 22, 2007, by Fresenius. It contains forward-looking statements, business updates, financial results for fiscal year 2006, and outlook for 2007. The content includes sales growth, EBIT margins, dividend proposals, and strategic accomplishments across various business segments. The document is structured as a presentation with slides and graphics, typical of investor presentations. It is not a full annual report (10-K), nor is it a brief earnings release or a regulatory filing. The presence of detailed financial data, strategic updates, and forward-looking guidance aligns with the definition of an Investor Presentation (IP). The document length (15,000 characters) and content depth support this classification with high confidence.
2007-02-22 English
Kapitalflussrechnung 2006
Annual Report Classification · 95% confidence The document contains detailed financial tables including cash flow statements (Konzern-Kapitalflussrechnung) for the years 2005 and 2006, with line items such as cash flows from operating, investing, and financing activities. It also references notes and annexes integral to the consolidated financial statements. The content is comprehensive and includes actual financial data rather than just an announcement or summary. The document length is under 5,000 characters but contains substantive financial data, indicating it is part of a financial report rather than a brief announcement. The presence of consolidated cash flow statements and detailed financial figures strongly suggests this is part of an Annual Report (10-K equivalent) or a full financial report. Given the detailed financial data and the nature of the content, the best classification is Annual Report (10-K). FY 2006
2007-02-22 German

Browse filings by year

31 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.